A Novartis investigational product called Bimagrumab recently raised attention in the obesity research community. The human monoclonal antibody was designed to treat muscle […]
A January 13 study published in JAMA Network Open looks at the “Effect of Bimagrumab vs. Placebo on Body Fat […]
This week, Rhythm Pharmaceuticals, a biopharmaceutical company specializing in the treatment of rare genetic diseases surrounding obesity, announced the U.S. […]
Obesity represents big business and big problems. The condition has essentially tripled since the 1970s as raising middle classes around […]
Kaiser Permanente Southern California researchers reviewed data covering almost 7,000 COVID-19 patients treated between February and May 2020. Nearly half […]
A team of researchers from Kaiser Permanente concluded in a study that obesity increases the risk of death from SARS-CoV-2, […]
A research team from the University of Buffalo School of Pharmacy and Pharmaceutical Sciences have received $10 million to commence […]
The FDA has requested that Eisai, the manufacturer of Belviq, Belviq XR (lorcaserin), voluntarily withdraw the weight-loss drug from the […]
Japan-based Eisai Pharmaceuticals pulled its anti-obesity drug Belviq from the U.S. market due to reports that it is associated with […]
Cedars-Sinai investigators have received $9.1 million by the National Cancer Institute to study how fat can promote cancer’s spread to […]
